EPA:DHA 6:1 is a superior omega-3 PUFAs formulation...

European Journal of Pharmacology 2019 / 06 Vol. 853

EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxide

Zgheel, Faraj, Perrier, Stéphanie, Remila, Lamia, Houngue, Ursula, Mazzucotelli, Jean-Philippe, Morel, Olivier, Auger, Cyril, Schini-Kerth, Valérie B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
853
Journal:
European Journal of Pharmacology
DOI:
10.1016/j.ejphar.2019.03.022
Date:
June, 2019
File:
PDF, 839 KB
2019
Conversion to is in progress
Conversion to is failed